Evidence map›Paper›PMID 26453755›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Tissue-Resident NK Cells Mediate Ischemic Kidney Injury and Are Not Depleted by Anti-Asialo-GM1 Antibody.

Francisco Victorino, Dorothy K Sojka, Kelley S Brodsky, Eoin N McNamee, Joanne C Masterson, Dirk Homann, Wayne M Yokoyama, Holger K Eltzschig, Eric T Clambey

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03487861 (Development of a Diagnostic Kit for Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis), which is not on this map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03487861 unknown statusnot on this mapstarted 2017, after this paper: background citation

Development of a Diagnostic Kit for Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis

TypeobservationalSponsorAsan Medical CenterRan2017 to 2020Enrolled1,000ConditionsKidney Allograft Fibrosis, Kidney Transplant Failure and RejectionArmsobservational(urinary biomarker for kidney allograft fibrosis)
3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 119 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. CD94The European respiratory journal · 2024
    Article
  11. Article
  12. Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Early immune and host cell responses toFrontiers in parasitology · 2023
    Article
  19. Metabolic signatures of immune cells in chronic kidney disease.Expert reviews in molecular medicine · 2022
    Review
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Francisco VictorinoDepartment of Anesthesiology, University of Colorado School of Medicine, Aurora, CO 80045; Immunology Graduate Program, University of Colorado School of Medicine, Aurora, CO 80045;ORCID http://orcid.org/0000-0001-7626-3219
Dorothy K SojkaRheumatology Division, Washington University School of Medicine, St. Louis, MO 63110;
Kelley S BrodskyDepartment of Anesthesiology, University of Colorado School of Medicine, Aurora, CO 80045;ORCID http://orcid.org/0000-0003-0732-7703
Eoin N McNameeDepartment of Anesthesiology, University of Colorado School of Medicine, Aurora, CO 80045;ORCID http://orcid.org/0000-0002-3331-3148
Joanne C MastersonGastrointestinal Eosinophilic Diseases Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO 80045; Digestive Health Institute, Children's Hospital Colorado, Aurora, CO 80045; and.ORCID http://orcid.org/0000-0002-8336-9879
Dirk HomannDepartment of Anesthesiology, University of Colorado School of Medicine, Aurora, CO 80045;
Wayne M YokoyamaRheumatology Division, Washington University School of Medicine, St. Louis, MO 63110; Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110.
Holger K EltzschigDepartment of Anesthesiology, University of Colorado School of Medicine, Aurora, CO 80045;
Eric T ClambeyDepartment of Anesthesiology, University of Colorado School of Medicine, Aurora, CO 80045; Eric.Clambey@ucdenver.edu.ORCID http://orcid.org/0000-0002-7972-9544
University of Colorado Denver · USChildren's Hospital Colorado · USHoward Hughes Medical Institute · USWashington University in St. Louis · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Trangenic Mouse Breeding CoreP01HL114457 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BLACKBURN, MICHAEL R · 2013 to 2017
$10.0M
Extracellular Adenosine During Ventilator Induced Lung InjuryR01HL092188 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ELTZSCHIG, HOLGER K. · 2009 to 2013
$2.1M
Regulation of Pathogen-specific T Cell Immunity by Adenosine GenerationR01AI093637 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOMANN, DIRK · 2012 to 2016
$2.0M
Proton Pump Inhibitors for Perioperative Acute Kidney InjuryR01DK097075 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ELTZSCHIG, HOLGER K. · 2013 to 2017
$1.7M
Hypoxia Inducible Factor in Acute Lung InjuryR01HL098294 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ELTZSCHIG, HOLGER K. · 2011 to 2014
$1.6M
Amphiregulin Signaling in Perioperative Cardio-ProtectionR01HL119837 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ELTZSCHIG, HOLGER K. · 2014 to 2017
$1.5M
LIVER-RESIDENT NATURAL KILLER CELLS, VIRAL INFECTION, HEPATITIS AND MEMORYR01AI106561 · NIAID · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 2013 to 2015
$589k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA046934NCI NIH HHS P30CA046934NHLBI NIH HHS P01 HL114457NHLBI NIH HHS P0I-HL114457NHLBI NIH HHS R01 HL092188NHLBI NIH HHS R01-HL092188NHLBI NIH HHS R01 HL098294NHLBI NIH HHS R01-HL098294NHLBI NIH HHS R01 HL119837NHLBI NIH HHS R01-HL119837NIAID NIH HHS R01 AI093637NIAID NIH HHS R01-AI093637NIAID NIH HHS R01 AI106561NIAID NIH HHS R01-AI106561NIDDK NIH HHS R01 DK097075NIDDK NIH HHS R01-DK097075
6 · The paper itself

Abstract

NK cells are innate lymphoid cells important for immune surveillance, identifying and responding to stress, infection, and/or transformation. Whereas conventional NK (cNK) cells circulate systemically, many NK cells reside in tissues where they appear to be poised to locally regulate tissue function. In the present study, we tested the contribution of tissue-resident NK (trNK) cells to tissue homeostasis by studying ischemic injury in the mouse kidney. Parabiosis experiments demonstrate that the kidney contains a significant fraction of trNK cells under homeostatic conditions. Kidney trNK cells developed independent of NFIL3 and T-bet, and they expressed a distinct cell surface phenotype as compared with cNK cells. Among these, trNK cells had reduced asialo-GM1 (AsGM1) expression relative to cNK cells, a phenotype observed in trNK cells across multiple organs and mouse strains. Strikingly, anti-AsGM1 Ab treatment, commonly used as an NK cell-depleting regimen, resulted in a robust and selective depletion of cNKs, leaving trNKs largely intact. Using this differential depletion, we tested the relative contribution of cNK and trNK cells in ischemic kidney injury. Whereas anti-NK1.1 Ab effectively depleted both trNK and cNK cells and protected against ischemic/reperfusion injury, anti-AsGM1 Ab preferentially depleted cNK cells and failed to protect against injury. These data demonstrate unanticipated specificity of anti-AsGM1 Ab depletion on NK cell subsets and reveal a new approach to study the contributions of cNK and trNK cells in vivo. In total, these data demonstrate that trNK cells play a key role in modulating local responses to ischemic tissue injury in the kidney and potentially other organs.

Indexed as

AnimalsAntibodiesG(M1) GangliosideIschemiaKidneyKidney DiseasesKiller Cells, NaturalMiceMice, Inbred BALB CMice, Inbred NODMice, KnockoutAntibodiesasialo GM1 gangliosideG(M1) Ganglioside

Identifiers

PMID26453755
PMCPMC4640895
OpenAlexW2400908316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.